Jiangxi Synergy Pharmaceutical

Fengxin, Jiangxi, China
Hybrid — also manufactures internal programs
Small Molecule API Intermediates
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (1) ○ EMA GMP ○ MHRA GMP ✓ HC GMP (1)

Quick Facts: Jiangxi Synergy Pharmaceutical

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
Fengxin, Jiangxi, China
Website
Modalities
Small Molecule API, Intermediates
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Jiangxi Synergy Pharmaceutical

Jiangxi Synergy Pharmaceutical makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API, Intermediates. 1 manufacturing site registered with the U.S. FDA and Health Canada. Website: http://www.jxsynergy.com/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data. This company's careers site asks automated readers not to collect it (robots.txt), and we respect that.
Source: public careers pages · Checked Oct 30, 2026

Company Signals 1 articles

Company announcements, not verified evidence. They do not change any score.
financial 2026-10-28
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2026 - www.marketscreener.com
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2026  www.marketscreener.com

Frequently Asked Questions About Jiangxi Synergy Pharmaceutical

Does Jiangxi Synergy Pharmaceutical have a CDMO Signal Score?
Not yet. Jiangxi Synergy Pharmaceutical is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Jiangxi Synergy Pharmaceutical for a manufacturing program?
Use the free AI matchmaker to compare Jiangxi Synergy Pharmaceutical against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

Changzhou Qihui Pharmaceutical
Changzhou, Jiangsu, China
Small Molecule API, Veterinary, Intermediates
Jiangxi Fushine Pharmaceutical
Jingdezhen, Jiangxi, China
Small Molecule API, Intermediates, Custom Synthesis
Shanghai Desano
Shanghai, China
Small Molecule API, Intermediates, Oral Solid Dose, Oligonucleotide
Agno Pharma
Lianyungang, Jiangsu, China
Small Molecule API, Intermediates, Sterile Injectables, Clinical Trial Manufacturing
PharmaBlock
Nanjing, Jiangsu, China
Small Molecule API, Intermediates, Oral Solid Dose

Compare Jiangxi Synergy Pharmaceutical with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Jiangxi Synergy Pharmaceutical
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.